Isomorphic Labs has completed $5 billion in Series C funding to advance its drug candidates into clinical trials, further develop its AI drug design engine, and expand into the healthcare sector.
Source:TechCrunch · Read Original
Isomorphic Labs has completed $5 billion in Series C funding to advance its drug candidates into clinical trials, further develop its AI drug design engine, and expand into the healthcare sector.
Source:TechCrunch · Read Original
Leave a Reply